Effects / Ill Effects of Alcohol in Older Adults and How to Address Alcoholism

Alcohol use disorder (AUD) is the commonest form of substance use disorder in older adults. Alcohol falls under socially sanctioned psychoactive substances, alongside medications (prescribed and non-prescribed) and illicit substances.

One-year community prevalence of AUD: 2.75% in elderly men and 0.51% in elderly women. Far higher in primary care, where at-risk drinking is 5–15%. Older military veterans have a particularly high prevalence.

Overall SUD prevalence is underestimated, because DSM-5 criteria have limited applicability to this age group — tolerance, work impairment and legal problems are poor markers in a retired, socially isolated person.

Two subgroups: early-onset (lifelong drinkers surviving into old age) and late-onset drinkers who begin heavy drinking in later life, often after bereavement, retirement or loss.

Reduced total body water and lean mass with increased fat gives a higher blood alcohol concentration for the same intake; reduced first-pass metabolism and hepatic blood flow prolong exposure.

The same amount of alcohol that caused no untoward social or physical effects in middle age now causes difficulty — which is precisely why older adults and their relatives are often in denial.

Even modest alcohol consumption produces excessive disability and poorer perceived health in older adults with chronic physical and mental health disorders.

The ageing brain is especially vulnerable — those who begin drinking heavily late in life show cognitive impairment comparable to those who have drunk for decades.

Neurocognitive. Alcohol-related cognitive decline is a recognised neurocognitive disorder. Chronic heavy intake causes brain atrophy and dementia; there is a doubling of the odds of later severe memory impairment in those with a history of AUD. Memory and executive function are worst affected, with prefrontal and frontal damage on neuroimaging. Contributions of alcohol, thiamine deficiency and ageing are hard to separate.

Persistence after abstinence. A lifetime history of alcohol dependence — even without current heavy use — causes sustained impairment in memory, motor and attention/executive domains. Word-list recall (free verbal recall) is a sensitive discriminator.

Even moderate-heavy drinking impairs brain networks. On functional MRI, moderate-heavy older drinkers show decreased central executive network connectivity during a working memory task, with no difference in default mode network connectivity.

Psychiatric. Worsens depression and anxiety, causes insomnia, and older adults with AUD face a greater risk of suicide.

Falls, injury and delirium. Impairs gait and balance, precipitates falls and fractures, and is a common precipitant of delirium — both from intoxication and from withdrawal.

Drug interactions. Combining alcohol with prescription and OTC medications, especially psychoactive agents, is a major hazard; cross-tolerance between alcohol and benzodiazepines is clinically important and, if unrecognised, leads to dependence being overlooked. 15% of over-65s requiring inpatient alcohol detoxification are dependent on a second substance, usually a hypnotic, anxiolytic or analgesic.

Systemic disease. Liver disease, pancreatitis, cardiomyopathy, arrhythmia, hypertension, malnutrition, anaemia, immunosuppression, and malignancy (alcohol is an IARC Group 1 carcinogen).

Social consequences. Self-neglect, financial loss, family and marital discord, and — importantly for the geriatrician — being an abuser or victim in elder mistreatment: a shared living arrangement with a relative suspected of alcohol or substance misuse is a recognised risk factor for elder abuse.

Observational evidence suggests moderate intake (1–3 standard drinks/day) may be associated with reduced risk of cognitive impairment. In the Framingham Offspring Cohort, late-life (not midlife) moderate consumers had larger hippocampal volume and light consumers better episodic memory than abstainers. In the MoVIES project, minimal and moderate drinking were associated with less decline on MMSE and Trail Making Test.

Interpret with great caution. In the reanalysed PAQUID study (20-year follow-up, 3676 subjects), dementia risk was lower only in light drinkers (HR 0.85), non-significant in moderate drinkers (HR 0.79) and neutral in heavy drinkers (HR 1.01). Likely explanation: light-to-moderate intake is merely a marker of a broader favourable psychosocial behaviour pattern, not a protective agent. Confounding dominates this literature — never advise an abstainer to start drinking.

Screening is part of CGA. The screening question is simply "Do you drink alcohol?", followed by CAGE questionnaire (primary screening tool), Michigan Alcohol Screening Test-9 / Short MAST-Geriatric version (SMAST-G).

Case-finding, not self-presentation. Older people present with physical problems, not with a drinking complaint. They may not realise they are ill or that help exists, they under-report, services staffed by young professionals feel intimidating, and stigma is high because the disorder is seen as self-inflicted. Physicians find it hard to discuss substance misuse with older people.

Approach. A non-judgemental and tactful approach is essential, especially in ageing women. Home carers and the multiple professional contacts an older person has are an underdeveloped opportunity for detection and need better training.

Brief interventions work. Structured brief intervention by primary care physicians — five minutes, five brief sessions targeting at-risk drinking — is often fairly effective.

Pharmacotherapy. There is some evidence supporting naltrexone. There is insufficient evidence to endorse disulfiram, acamprosate or topiramate in older adults.

Education on interactions. Specific advice about combining alcohol with prescription and OTC drugs, especially psychoactive agents, must be given and regularly reinforced.

Psychosocial approaches must be routine — support groups, Alcoholics Anonymous, individual counselling and family intervention — alongside treatment of comorbid depression, which perpetuates the disorder.

WHO 2023 — the "no safe level" statement. In January 2023 the WHO stated in The Lancet Public Health that while cancer risk rises substantially with amount consumed, there is no threshold below which alcohol is safe, whatever the beverage type. IARC classifies alcohol as a Group 1 carcinogen; it is a major risk factor for oral, pharyngeal, laryngeal, oesophageal, liver, pancreatic, colorectal and breast cancer, accounting for about 741,300 new cancer cases (4%) worldwide annually.

US Surgeon General Advisory, January 2025. Issued an advisory on the alcohol– cancer link, calling for cancer warning labels on alcoholic beverages and for health professionals to routinely discuss alcohol use with patients. Alcohol is now described as a leading cause of cancer after tobacco and obesity, accounting for about 5% (~97,000) of new US cancer cases.

But the evidence is contested — needed for a balanced answer. The 2018 Global Burden of Disease study concluded zero alcohol was safest, but its 2022 update introduced an age-specific, risk-weighted model asserting that in populations with high baseline cardiovascular disease rates — particularly older adults — light-to-moderate consumption could carry net health benefits. In January 2025 the Surgeon General discouraged any intake while a simultaneous NASEM (National Academies) report emphasised tailoring recommendations to individual risk, finding no association between moderate consumption and colorectal, oral cavity, pharyngeal, oesophageal or laryngeal cancers. Mendelian randomisation studies, however, found no benefit and increased risk even at low doses.

Public awareness is poor. A 2025 JAMA Oncology analysis of the 2024 Health Information National Trends Survey (6,793 US adults) found only 37% knew alcohol increases cancer risk, and about 9% believed it had no effect or reduced risk.

Treatment gap remains enormous. An estimated 29 million US residents had AUD in 2023, yet only about 2% received pharmacological treatment. Alcohol-related deaths in the US have risen by 29% since 2020, driven mainly by liver disease.

Reduction, not only abstinence, is now an accepted goal. Reducing drinking even without full abstinence improves health outcomes — a harm-reduction framing particularly suited to frail older patients in whom total abstinence may be unrealistic.

AUD is the commonest substance use disorder in older adults.

Prevalence: 2.75% elderly men, 0.51% elderly women; 5–15% at-risk drinking in primary care.

DSM-5 criteria are poorly applicable to older adults → under-diagnosis.

Same intake, higher blood level — less body water, more fat, reduced first-pass metabolism.

Even modest intake causes excessive disability in those with chronic disease.

Alcohol-related cognitive decline = a named neurocognitive disorder; doubling of odds of severe memory impairment.

Memory and executive function worst hit; prefrontal/frontal atrophy.

Late-onset drinkers are as impaired as lifelong drinkers — the ageing brain is uniquely vulnerable.

Higher suicide risk in older adults with AUD.

Screening = CAGE / SMAST-G; ask "Do you drink alcohol?" in every CGA.

Brief intervention = 5 minutes × 5 sessions.

Naltrexone has some evidence; disulfiram, acamprosate, topiramate — insufficient evidence in the elderly.

Alcohol = IARC Group 1 carcinogen; WHO 2023: no safe level.